Statements (38)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:activeIngredient |
pneumococcal polysaccharide conjugated to CRM197 protein
|
| gptkbp:age |
adults 18 years and older
children 6 weeks and older |
| gptkbp:alternativeTo |
gptkb:Pneumovax_23
gptkb:Prevnar_13 |
| gptkbp:approvalYear |
2021
|
| gptkbp:approvedBy |
gptkb:European_Medicines_Agency
gptkb:U.S._Food_and_Drug_Administration |
| gptkbp:ATCCode |
J07AL03
|
| gptkbp:containsSerotype |
gptkb:18C
gptkb:19F gptkb:23F 1 14 3 4 5 6B 9V 6A 19A 7F 22F 33F |
| gptkbp:countryOfOperation |
gptkb:European_Union
gptkb:United_States |
| gptkbp:form |
suspension for injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
Vaxneuvance
|
| gptkbp:indication |
prevention of invasive disease caused by Streptococcus pneumoniae
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Merck_&_Co.
|
| gptkbp:routeOfAdministration |
intramuscular injection
|
| gptkbp:storage |
2°C to 8°C
|
| gptkbp:targetPathogen |
gptkb:Streptococcus_pneumoniae
|
| gptkbp:vaccineType |
vaccine
|
| gptkbp:bfsParent |
gptkb:PCV15
|
| gptkbp:bfsLayer |
5
|